Literature DB >> 22301416

CD4 T-cell regeneration in HIV-1 elite controllers.

Yue Yang1, Maha Al-Mozaini, Maria J Buzon, Jill Beamon, Sara Ferrando-Martinez, Ezequiel Ruiz-Mateos, Eric S Rosenberg, Florencia Pereyra, Xu G Yu, Mathias Lichterfeld.   

Abstract

BACKGROUND: Elite controllers spontaneously control HIV-1 replication, which in many cases is associated with preservation of normal CD4 T-cell counts. However, a subset of elite controllers has progressive CD4 T-cell losses despite undetectable viral loads, for reasons that remain undefined. Here, we assessed mechanisms of CD4 T-cell homeostasis in elite controllers with progressive vs. nonprogressive HIV-1 disease courses.
METHODS: Flow cytometry assays were used to determine the proliferation, activation and apoptosis levels of naive T cells in elite controllers with high or low CD4 T-cell counts and reference cohorts of HIV-1-negative and HAART-treated persons. Thymic output was measured by single-joint T-cell receptor excision circle (sjTREC)/β T-cell receptor excision circle (βTREC) ratios, and the frequency of circulating recent thymic emigrants was flow cytometrically determined by surface expression of protein tyrosine kinase 7.
RESULTS: Proportions of naive T cells in elite controllers were severely reduced and closely resemble those of HIV-1 patients with progressive disease. Despite reductions in naive T cells, most elite controllers were able to maintain normal total CD4 T-cell counts by preservation of uncompromised thymic function in conjunction with extrathymic processes that led to elevated levels of circulating recent thymic emigrants. In contrast, elite controllers with low CD4 T-cell counts had reduced thymic output that mirrored thymic dysfunction during untreated progressive HIV-1 infection.
CONCLUSION: These results indicate that both thymic and extrathymic mechanisms contribute to CD4 T-cell maintenance in elite controllers and support the idea that CD4 T-cell homeostasis and control of viral replication are distinct but frequently coinciding processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301416      PMCID: PMC3729591          DOI: 10.1097/QAD.0b013e3283519b22

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  19 in total

Review 1.  Development of alphabeta T cells in the human thymus.

Authors:  Hergen Spits
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

2.  Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.

Authors:  Florencia Pereyra; Sarah Palmer; Toshiyuki Miura; Brian L Block; Ann Wiegand; Alissa C Rothchild; Brett Baker; Rachel Rosenberg; Emily Cutrell; Michael S Seaman; John M Coffin; Bruce D Walker
Journal:  J Infect Dis       Date:  2009-09-15       Impact factor: 5.226

3.  A reliable and simplified sj/beta-TREC ratio quantification method for human thymic output measurement.

Authors:  Sara Ferrando-Martínez; Jaime M Franco; Ezequiel Ruiz-Mateos; Ana Hernández; Antonio Ordoñez; Encarnación Gutierrez; Manuel Leal
Journal:  J Immunol Methods       Date:  2009-11-15       Impact factor: 2.303

4.  T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers.

Authors:  Philomena Kamya; Christos M Tsoukas; Salix Boulet; Jean-Pierre Routy; Réjean Thomas; Pierre Côté; Mohamed-Rachid Boulassel; Bernard Lessard; Rupert Kaul; Mario Ostrowski; Colin Kovacs; Cecile L Tremblay; Nicole F Bernard
Journal:  AIDS Res Ther       Date:  2011-06-16       Impact factor: 2.250

5.  T cell homeostasis: thymus regeneration and peripheral T cell restoration in mice with a reduced fraction of competent precursors.

Authors:  A R Almeida; J A Borghans; A A Freitas
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

6.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

7.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.

Authors:  Peter W Hunt; Jason Brenchley; Elizabeth Sinclair; Joseph M McCune; Michelle Roland; Kimberly Page-Shafer; Priscilla Hsue; Brinda Emu; Melissa Krone; Harry Lampiris; Daniel Douek; Jeffrey N Martin; Steven G Deeks
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

8.  Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.

Authors:  Jason F Okulicz; Vincent C Marconi; Michael L Landrum; Scott Wegner; Amy Weintrob; Anuradha Ganesan; Braden Hale; Nancy Crum-Cianflone; Judith Delmar; Vincent Barthel; Gerald Quinnan; Brian K Agan; Matthew J Dolan
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

Review 9.  Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?

Authors:  Joel N Blankson
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

10.  Altered representation of naive and memory CD8 T cell subsets in HIV-infected children.

Authors:  R L Rabin; M Roederer; Y Maldonado; A Petru; L A Herzenberg; L A Herzenberg
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

View more
  16 in total

Review 1.  Unravelling the mechanisms of durable control of HIV-1.

Authors:  Bruce D Walker; Xu G Yu
Journal:  Nat Rev Immunol       Date:  2013-07       Impact factor: 53.106

2.  Thymic Function Failure Is Associated With Human Immunodeficiency Virus Disease Progression.

Authors:  Sara Ferrando-Martinez; Rebeca S De Pablo-Bernal; Marta De Luna-Romero; Santiago J De Ory; Miguel Genebat; Yolanda M Pacheco; Francisco J Parras; Marta Montero; Jose Ramón Blanco; Felix Gutierrez; Jesus Santos; Francisco Vidal; Richard A Koup; María Ángeles Muñoz-Fernández; Manuel Leal; Ezequiel Ruiz-Mateos
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

3.  HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.

Authors:  B Dominguez-Molina; L Tarancon-Diez; S Hua; C Abad-Molina; E Rodriguez-Gallego; K Machmach; F Vidal; C Tural; S Moreno; J M Goñi; E Ramírez de Arellano; M Del Val; M F Gonzalez-Escribano; J Del Romero; C Rodriguez; L Capa; P Viciana; J Alcamí; X G Yu; B D Walker; Manuel Leal; M Lichterfeld; E Ruiz-Mateos
Journal:  Clin Infect Dis       Date:  2016-12-16       Impact factor: 9.079

4.  Effect of human immunodeficiency virus infection on plasma bactericidal activity against Salmonella enterica serovar Typhimurium.

Authors:  Estela Trebicka; Nanda Kumar N Shanmugam; Anastassia Mikhailova; Galit Alter; Bobby J Cherayil
Journal:  Clin Vaccine Immunol       Date:  2014-08-13

5.  Late-emerging strains of HIV induce T-cell homeostasis failure by promoting bystander cell death and immune exhaustion in naïve CD4 and all CD8 T-cells.

Authors:  Catherine N Kibirige; Frederick A Menendez; Hao Zhang; Tricia L Nilles; Susan Langan; Joseph B Margolick
Journal:  Med Hypotheses       Date:  2014-04-13       Impact factor: 1.538

Review 6.  T-cell therapies for HIV: Preclinical successes and current clinical strategies.

Authors:  Shabnum Patel; R Brad Jones; Douglas F Nixon; Catherine M Bollard
Journal:  Cytotherapy       Date:  2016-06-02       Impact factor: 5.414

7.  Naïve CD4+ cell counts significantly decay and high HIV RNA levels contribute to immunological progression in long-term non-progressors infected with HIV by blood products: a cohort study.

Authors:  Ling Xu; Yubin Liu; Xiaojing Song; Yanling Li; Yang Han; Ting Zhu; Wei Cao; Taisheng Li
Journal:  BMC Immunol       Date:  2021-06-03       Impact factor: 3.615

8.  Different immunological phenotypes associated with preserved CD4+ T cell counts in HIV-infected controllers and viremic long term non-progressors.

Authors:  Julie Christine Gaardbo; Hans J Hartling; Andreas Ronit; Kristina Thorsteinsson; Hans Ole Madsen; Karoline Springborg; Lise Mette Rahbek Gjerdrum; Carsten Birch; Matthew Laye; Henrik Ullum; Åse Bengaard Andersen; Susanne Dam Nielsen
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

9.  Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.

Authors:  Luca Genovese; Manuela Nebuloni; Massimo Alfano
Journal:  Front Immunol       Date:  2013-04-09       Impact factor: 7.561

10.  Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS.

Authors:  Iart Luca Shytaj; Barbara Chirullo; Wendeline Wagner; Maria G Ferrari; Rossella Sgarbanti; Alessandro Della Corte; Celia LaBranche; Lucia Lopalco; Anna Teresa Palamara; David Montefiori; Mark G Lewis; Enrico Garaci; Andrea Savarino
Journal:  Retrovirology       Date:  2013-07-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.